Labor & Delivery
Acceptable level of maternal and neonate side effects found with patient-controlled analgesia
Published in Women's Health Weekly, November 10th, 2005
"Remifentanil has been suggested as an ideal opioid for patient-controlled analgesia (PCA) in labor, but the safety profile has not been established. The aims of a preliminary prospective observational study" by scientists in England "were to investigate the maternal side-effects and early neonatal effects, and to assess the placental transfer of remifentanil PCA during labor."
"Women with no known obstetric complications or contraindication to remifentanil were recruited (n=50)," wrote I. Volikas and colleagues. "Remifentanil was...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Women's Health Weekly
More Articles from Women's Health Weekly
- Cancer Risk Factors
Parental consanguinity in Arabs not associated with higher risk of breast cancer - HIV/AIDS Transmission
Planned caesarian section is safe and effective for preventing transmission of HIV - Menopause
Testosterone therapy improves sexual function in post-menopausal women - Ovarian Cancer
Twelve cohort studies indicate risk of ovarian cancer not linked to fruit and vegetable diet - Type 2 Diabetes
Visceral adipose tissue and type 2 diabetes highest among Filipino women - Alcohol Use
Prenatal exposure to alcohol may cause visual problems in infants - More from this issue of Women's Health Weekly
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
